Emerging evidence suggests that the tumour microenvironment pattern and clinicopathological features of ccRCC are correlated with the prognosis and response to anti-angiogenic agents targeting VEGFR and immune checkpoint inhibitors (Kim et al., 2021). Here, KDR is linked to neoplasm.